Qube Research & Technologies (QRT)’s Elevance Health ELV Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.22M	Sell	7,600 -12,300	-62%	-$4.04M	﹤0.01%	2104
2025 Q4	$6.98M	Sell	19,900 -11,100	-36%	-$3.75M	0.01%	1568
2025 Q3	$10M	Buy	31,000 +10,100	+48%	+$3.14M	0.01%	1323
2025 Q2	$8.13M	Buy	20,900 +7,900	+61%	+$3.18M	0.01%	1415
2025 Q1	$5.65M	Sell	13,000 -6,900	-35%	-$2.77M	0.01%	1456
2024 Q4	$7.34M	Sell	19,900 -43,000	-68%	-$18M	0.01%	1281
2024 Q3	$32.7M	Sell	62,900 -6,500	-9%	-$3.47M	0.05%	479
2024 Q2	$37.6M	Buy	69,400 +11,900	+21%	+$6.29M	0.06%	382
2024 Q1	$29.8M	Buy	57,500 +45,200	+367%	+$22.5M	0.05%	446
2023 Q4	$5.8M	Buy	+12,300	New	+$5.69M	0.01%	962

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ELV Position: Q1 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Elevance Health (ELV) in Q1 2026: 112,717 shares worth $33M. The stake represents 0.04% of the portfolio and ranks #610 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in ELV as recently as Q1 2025.

Qube Research & Technologies (QRT) first reported a position in ELV in Q1 2018 and has held it in 25 quarters since. The position peaked at $227M in Q1 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

Qube Research & Technologies (QRT) held 112,717 shares of Elevance Health worth $33M as of Q1 2026.
Elevance Health was a new Qube Research & Technologies (QRT) position in Q1 2026.
Elevance Health made up 0.04% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #610 holding.
Qube Research & Technologies (QRT) first reported a position in Elevance Health in Q1 2018 and has held it in 25 quarters since.
Qube Research & Technologies (QRT)'s Elevance Health position peaked at $227M in Q1 2024.
1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.